2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Thomas Lynch, Jr, MD, Vice President and Chief Scientific Officer at Bristol-Myers Squibb, discusses goals at Bristol-Myers Squibb.
Thomas Lynch, Jr, MD, Vice President and Chief Scientific Officer at Bristol-Myers Squibb, discusses the goals of Bristol-Myers Squibb.
Lynch believes that physicians are motivated by 2 things—the desire to help patients and the sense of mission of the hospital, doctors, and nurses. These caregivers are working together for a common cause. Bristol-Myers Squibb embodies that same sense of a common cause, explains Lynch. The common cause centers around the idea of scientists, regulatory agencies, and clinical trial developers working together to create better medicine, states Lynch.
Over the next several years, Lynch says that his goals are to improve the ability of these medicines to make a difference in improving the cure rate for cancers and help people live longer, he says.
Related Content: